AC
EW icon

Armistice Capital’s Edwards Lifesciences EW Stock Holding History

Armistice Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.86M Sell
97,918
-126,917
-56% -$10.6M 0.11% 114
2026
Q1 		$18M Sell
224,835
-52,643
-19% -$4.34M 0.32% 63
2025
Q4 		$23.7M Buy
277,478
+130,907
+89% +$10.7M 0.28% 58
2025
Q3 		$11.4M Buy
+146,571
New +$11.5M 0.17% 80
2025
Q2 		– Sell
-62,995
Closed -$4.57M – 225
2025
Q1 		$4.57M Sell
62,995
-106,834
-63% -$7.65M 0.07% 119
2024
Q4 		$12.6M Buy
169,829
+4,834
+3% +$338K 0.17% 86
2024
Q3 		$10.9M Buy
+164,995
New +$12M 0.17% 89

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Armistice Capital's EW Position: Q2 2026 in Review

Armistice Capital reduced its Edwards Lifesciences (EW) stake by 56% in Q2 2026, selling an estimated $10.6M and leaving 97,918 shares worth $8.86M. The position accounts for 0.11% of the portfolio, ranked #114.

Armistice Capital first reported a position in EW in Q3 2024 and has held it in 7 quarters since. The position peaked at $23.7M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Armistice Capital held 97,918 shares of Edwards Lifesciences worth $8.86M as of Q2 2026.
  • Armistice Capital sold 126,917 Edwards Lifesciences shares in Q2 2026, an estimated $10.6M.
  • Edwards Lifesciences made up 0.11% of Armistice Capital's portfolio in Q2 2026, its #114 holding.
  • Armistice Capital first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 7 quarters since.
  • Armistice Capital's Edwards Lifesciences position peaked at $23.7M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.